NR1H4 and cholestasis: Administration of P. copri may regulate the activity of BA receptors (mainly FXR) by enriching the number of Muribagulaceae (family S24–7) and Clostridium, thereby improving BAs transport and inhibiting BAs synthesis to alleviate cholestasis in the liver.